These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 34222276)

  • 1. Glomerular Endothelial Cells Are the Coordinator in the Development of Diabetic Nephropathy.
    Li T; Shen K; Li J; Leung SWS; Zhu T; Shi Y
    Front Med (Lausanne); 2021; 8():655639. PubMed ID: 34222276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-Cell RNA Profiling of Glomerular Cells Shows Dynamic Changes in Experimental Diabetic Kidney Disease.
    Fu J; Akat KM; Sun Z; Zhang W; Schlondorff D; Liu Z; Tuschl T; Lee K; He JC
    J Am Soc Nephrol; 2019 Apr; 30(4):533-545. PubMed ID: 30846559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF-
    Hong Q; Zhang L; Fu J; Verghese DA; Chauhan K; Nadkarni GN; Li Z; Ju W; Kretzler M; Cai GY; Chen XM; D'Agati VD; Coca SG; Schlondorff D; He JC; Lee K
    J Am Soc Nephrol; 2019 Apr; 30(4):546-562. PubMed ID: 30858225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular endothelial cells versus podocytes as the cellular target in diabetic nephropathy.
    Maestroni S; Zerbini G
    Acta Diabetol; 2018 Nov; 55(11):1105-1111. PubMed ID: 30155580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model.
    Masuda K; Tanabe K; Ujike H; Hinamoto N; Miyake H; Tanimura S; Sugiyama H; Sato Y; Maeshima Y; Wada J
    PLoS One; 2018; 13(4):e0195779. PubMed ID: 29641565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell biology of diabetic nephropathy: Roles of endothelial cells, tubulointerstitial cells and podocytes.
    Maezawa Y; Takemoto M; Yokote K
    J Diabetes Investig; 2015 Jan; 6(1):3-15. PubMed ID: 25621126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Enhanced Leucine-Rich
    Haku S; Wakui H; Azushima K; Haruhara K; Kinguchi S; Ohki K; Uneda K; Kobayashi R; Matsuda M; Yamaji T; Yamada T; Minegishi S; Ishigami T; Yamashita A; Ohashi K; Tamura K
    Biomed Res Int; 2018; 2018():2817045. PubMed ID: 30515388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic Kidney Disease, Endothelial Damage, and Podocyte-Endothelial Crosstalk.
    Gil CL; Hooker E; Larrivée B
    Kidney Med; 2021; 3(1):105-115. PubMed ID: 33604542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerular Endothelial Cell Crosstalk With Podocytes in Diabetic Kidney Disease.
    Mahtal N; Lenoir O; Tharaux PL
    Front Med (Lausanne); 2021; 8():659013. PubMed ID: 33842514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular mesangial cell and podocyte injuries in diabetic nephropathy.
    Tung CW; Hsu YC; Shih YH; Chang PJ; Lin CL
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():32-37. PubMed ID: 30298646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Slit2/Robo1 signaling is involved in angiogenesis of glomerular endothelial cells exposed to a diabetic-like environment.
    Liu J; Hou W; Guan T; Tang L; Zhu X; Li Y; Hou S; Zhang J; Chen H; Huang Y
    Angiogenesis; 2018 May; 21(2):237-249. PubMed ID: 29299781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic Nephropathy.
    Oltean S; Qiu Y; Ferguson JK; Stevens M; Neal C; Russell A; Kaura A; Arkill KP; Harris K; Symonds C; Lacey K; Wijeyaratne L; Gammons M; Wylie E; Hulse RP; Alsop C; Cope G; Damodaran G; Betteridge KB; Ramnath R; Satchell SC; Foster RR; Ballmer-Hofer K; Donaldson LF; Barratt J; Baelde HJ; Harper SJ; Bates DO; Salmon AH
    J Am Soc Nephrol; 2015 Aug; 26(8):1889-904. PubMed ID: 25542969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
    Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G
    Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-associated nephropathy: experimental models.
    Avila-Casado C; Fortoul TI; Chugh SS
    Contrib Nephrol; 2011; 169():270-285. PubMed ID: 21252526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGFC Reduces Glomerular Albumin Permeability and Protects Against Alterations in VEGF Receptor Expression in Diabetic Nephropathy.
    Onions KL; Gamez M; Buckner NR; Baker SL; Betteridge KB; Desideri S; Dallyn BP; Ramnath RD; Neal CR; Farmer LK; Mathieson PW; Gnudi L; Alitalo K; Bates DO; Salmon AHJ; Welsh GI; Satchell SC; Foster RR
    Diabetes; 2019 Jan; 68(1):172-187. PubMed ID: 30389746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glomerular cell number in normal subjects and in type 1 diabetic patients.
    Steffes MW; Schmidt D; McCrery R; Basgen JM;
    Kidney Int; 2001 Jun; 59(6):2104-13. PubMed ID: 11380812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats.
    Okada M; Takemura T; Yanagida H; Yoshioka K
    Kidney Int; 2002 Jan; 61(1):113-24. PubMed ID: 11786091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term expression of glomerular genes in diabetic nephropathy.
    Chittka D; Banas B; Lennartz L; Putz FJ; Eidenschink K; Beck S; Stempfl T; Moehle C; Reichelt-Wurm S; Banas MC
    Nephrol Dial Transplant; 2018 Sep; 33(9):1533-1544. PubMed ID: 29340699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular Endothelial Cells as Instigators of Glomerular Sclerotic Diseases.
    Sol M; Kamps JAAM; van den Born J; van den Heuvel MC; van der Vlag J; Krenning G; Hillebrands JL
    Front Pharmacol; 2020; 11():573557. PubMed ID: 33123011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy.
    Yamamoto Y; Maeshima Y; Kitayama H; Kitamura S; Takazawa Y; Sugiyama H; Yamasaki Y; Makino H
    Diabetes; 2004 Jul; 53(7):1831-40. PubMed ID: 15220208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.